Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
56.66 Thousand
revenue per share TTM
0.02$
valuation ratios | |
|---|---|
| pe ratio | -0.35 |
| peg ratio | -0.01 |
| price to book ratio | 2.32 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -0.72 |
| price fair value | 2.32 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -187.42% |
| return on equity | -264.79% |
| return on capital employed | -358.2% |
liquidity ratios | |
|---|---|
| current ratio | 1.90 |
| quick ratio | 1.90 |
| cash ratio | 1.71 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | -15,675.27 |
| cash conversion cycle | 15,675.27 |
| receivables turnover | 0.00 |
| payables turnover | -0.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | 0.32 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.24 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -12.15 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.38 |
| cash per share | 1.97 |
| operating cash flow per share | -4.38 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -12.15 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -2,006.95 |
Frequently Asked Questions
When was the last time Cellectar Biosciences, Inc. (NASDAQ:CLRB) reported earnings?
Cellectar Biosciences, Inc. (CLRB) published its most recent earnings results on 14-05-2026.
What is Cellectar Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Cellectar Biosciences, Inc. (NASDAQ:CLRB)'s trailing twelve months ROE is -264.79%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Cellectar Biosciences, Inc. (CLRB) currently has a ROA of -187.42%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CLRB's net profit margin stand at?
CLRB reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CLRB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.90 in the most recent quarter. The quick ratio stood at 1.90, with a Debt/Eq ratio of 0.32.